Vineet Kshirsagar, who serves as Chief Strategy Officer at Standex International Corporation, reported a sale of 400 shares of the companys common stock on February 18, 2026. The stock was sold at $260.1 per share, producing proceeds of $104,040, according to a Form 4 filing with the Securities and Exchange Commission.
The sale took place while Standex shares were trading near their 52-week high of $270.87. Over the past year the stock has delivered a total return of 38%.
Following the February 18 transaction, Kshirsagars direct holding in the company stands at 4,647 shares. The filing does not disclose any additional transactions beyond this sale and the resulting ownership balance.
Separately, a professional research assessment included in company-related analysis indicates Standex currently appears overvalued when measured against a fair value assessment. That analysis reports the stock is trading at a price-to-earnings ratio of 57. For investors seeking additional perspective, a Pro Research Report and a set of ProTips are available for this company and more than 1,400 other U.S. equities.
Standex also recently released financial results for the second quarter of fiscal 2026 that exceeded market expectations. The company posted earnings per share of $2.08, above the consensus forecast of $2.00. Revenue for the quarter came in at $221.3 million, compared with an anticipated $219.22 million. Those results signal that the firm outperformed analyst estimates on both the profit and top-line fronts during the period.
While the filing documents an insider sale and the research note flags a valuation premium, the companys quarterly results reflect stronger-than-expected operating performance. The article does not provide additional details on subsequent stock price movement following the earnings announcement or the insider transaction.
Context and immediate facts
- Insider transaction: 400 shares sold on February 18, 2026 at $260.1 per share, totaling $104,040.
- Post-sale ownership: Kshirsagar owns 4,647 shares directly.
- Market and valuation notes: stock trading near 52-week high of $270.87 and up 38% over the past year; research indicates a P/E of 57 and an overvalued fair value assessment.
- Quarterly results: Q2 FY2026 EPS $2.08 vs. $2.00 forecast; revenue $221.3 million vs. $219.22 million expected.
This report is limited to the facts contained in the regulatory filing, the published valuation assessment, and the companys quarterly results as reported. It does not draw causal conclusions about the motives behind the insider sale or future share price movements.